245 results
Page 8 of 13
S-4/A
318y y6aq
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.2
v9eg 2m6rmx
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.45
5dvop rqbfc6odk
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
sz4ufceqsem 907k7pn
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
8-K
EX-10.1
zkkeiu
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-10.1
4fpkddty qzgx
1 Nov 18
Business combination disclosure
5:00pm
425
22a7dvb
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.1
y77kq72ijbw6n3b
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
hzc8h0hvs 776
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.2
awc4cgl1r8s fyih
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
e5h3 9hx567jzhuxw2c4
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.3
2ng3a iquz5oy33le5
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.3
13uu8ymh3brgqzsoq 4y
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.2
0vsdubfudblts 8z
9 Aug 18
Business combination disclosure
5:17pm
425
cpbwsc7
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
kmdse5e
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
hxyjdwj16 8uljl84ul
9 Aug 18
Business combination disclosure
5:17pm